Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 527 participants.
Also called NCT03947619
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 527 participants
- Sponsor
- Registry
-
NCT03947619
-
- Other papers using this trial's data
- Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction Without Shock: The ST-Segment Elevation Myocardial Infarction Door to Unload Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States, Canada, Germany, Italy, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03947619. Randomized; single masking; primary purpose treatment. Start 2019-12-12 (actual); primary completion 2024-09-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
- Acronym
- DTU-STEMI
- Condition
- ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
- Intervention (Device)
- Impella CP® placement prior to reperfusion with Primary PCI
- Lead sponsor
- Abiomed Inc.
Record details
- Record id
cardio:ct-nct03947619- Content hash
154d0f908e6a87f85047c837c5be6c3331e1bb29ee4c2f1212f40482b4d4b8c4